Ali Fakhari-Dehkharghani
7PUBLICATIONS
24CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Nov 07, 2025
Cerebrolysin ameliorates ketamine-mediated anxiety and cognitive impairments via modulation of mitochondrial function and CREB/PGC-1α pathway.Leila Hosseini, Nasrin Abolhasanpour, Fatemehsadat Seyedaghamiri
|Jul 16, 2025
Effects of cerebrolysin on behavioral changes and the tryptophan-kynurenine pathway in the prefrontal cortex of male mice in the ketamine model of schizophrenia.Vida Mafikandi, Leila Hosseini, Fatemehsadat Seyedaghamiri
|May 15, 2025
Prescription pattern of driving-impairing psychotropic medications in Tabriz in 2022.Mostafa Farahbakhsh, Ali Fakhari, Ehsan Aghajani
|Jun 22, 2023
The Therapeutic Effect of Electroconvulsive Therapy in Patients With Obsessive-compulsive Disorder: A Quasi-experimental Study.Seyed Gholamreza Noorazar, Somayyeh Emamizad, Ali Fakhari-Dehkharghani
|Aug 27, 2021
The effects of lemon balm (Melissa officinalis L.) on depression and anxiety in clinical trials: A systematic review and meta-analysis.Javid Ghazizadeh, Saeed Sadigh-Eteghad, Wolfgang Marx
|Nov 29, 2019
Associations between optimism, tobacco smoking and substance abuse among Iranian high school students.Soudabeh Marin, Esmaeil Heshmatian, Haidar Nadrian
Pageof 2
Frequent Collaborators
2 joint publications
Asghar Mohammadpoorasl
2 joint publications
Leila Hosseini
1 joint publications
Kourosh Kabir
1 joint publications
Ali Bahari
1 joint publications
Mohammad Hajizadeh
1 joint publications
Hamid Allahverdipour
1 joint publications
Mohammad Javad Tarrahi
1 joint publications
Hossein Ansari
1 joint publications
Soudabeh Marin
1 joint publications
Haidar Nadrian
